Page 56 - Prostate News Today

University of California prostate cancer experts will share clinical insights at the first annual PSMA Conference, “PSMA PET and RLT: Present and Future.”

Prostate cancer is the second most common cancer in men worldwide, and the fourth overall, according to the World Cancer Research Fund. Click to read more...

The Cancer Society and Prostate Cancer Foundation both support piloting prostate cancer screening. The foundation says screening will save lives and health...

Researchers assessed ethnic and racial differences in novel hormonal therapy (NHT) use among advanced prostate cancer (PCa) patients.

Prostate health is essential for men's overall well-being, and maintaining it involves a combination of lifestyle choices and awareness. Here's a guid

Transcription factors play essential roles in turning the genetic information encoded in genes into proteins in all cells and organisms.

A breakthrough treatment for prostate cancer is being rolled to NHS clinics across the country.

The BMC Medicine study confirms that adhering to the 2018 World Cancer Research Fund/American Institute for Cancer Research recommendations significantly lowers the risk of various cancers, including breast, colorectal, and esophageal, in the UK population. This highlights the importance of lifestyle choices in cancer prevention.

A new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center found Black men diagnosed with more advanced stages of prostate cancer are significantly less likely to be prescribed novel hormone therapy than other racial and ethnic groups – including white or Latino men – despite the therapy being proven to effectively control the growth of prostate tumors and extend the lives of men with the disease.

Researchers examined associations between adherence to cancer prevention recommendations by the World Cancer Research Fund (WCRF)/American Institute for Cancer Research (AICR) and cancer risk.